Language:
ar enExperience:
7Nationality:
SudanDOH
GD24214Experienced in adult Psychiatry with strong background in clinical care, teaching and research currently practicing at the Behavioral science Institute Al Ain Hospital and serving as an adjunct faculty at UAE University. Published author and active contributor to psychiatric education and quality improvement. Has a compassionate and holistic approach to the patient well-being. Has a strong foundation in clinical practice and deep understanding of psychological complexities, she offers tailored treatment plan that impowers individual recovery and resilience. Committed to continuous learning and integrates the latest evidence-based methods in her work.
Feb 2018 - Present
Psychiatry Specialist at Al Ain Hospital
MBBS, psychiatry a report
Prevalence and risk factors for metabolic syndrome in schizophrenia, schizoaffective, and bipolar disorder.
Abstract Background Metabolic Syndrome (MetS) is a risk for developing cardiovascular diseases and its prevalence is especially high in psychiatric patients. To date, there is limited data from the United Arab Emirates (UAE) on the prevalence of MetS. Therefore, we aimed to investigate its prevalence and possible risk factors in a large sample of psychiatric patients in the UAE. Methods A cross-sectional study was conducted at Al-Ain Hospital, in Al-Ain City, UAE. We collected demographic and clinical data on patients diagnosed with schizophrenia, schizoaffective, and bipolar affective disorder in the period between January 2017 and December 2020. This included their secondary diagnosis (psychiatric or medical), vital signs (heart rate, systolic and diastolic blood pressure, Body Mass Index [BMI]), metabolic parameters (fasting blood glucose, cholesterol, triglycerides, low-density lipoprotein, high-density lipoproteins), and prescribed medications. We used the American Association of Clinical Endocrinology (AACE) criteria to diagnose MetS. Results We included 889 subjects and of these, 79.8% (N = 709) had a BMI ≥25 kg/m2 and 9.8% (N = 87) had no abnormal metabolic parameters. Overall, 28.1% (N = 250) had MetS with no statistical difference between the three groups. Fasting blood glucose levels and abnormally elevated triglycerides were significant predictors for MetS. Conclusion Our study found that around one in three patients had MetS irrespective of the three diagnoses. Some variables were significant predictors for MetS. Our findings were consistent with other studies and warrant the need for regular screening and management of abnormal metabolic parameters. • Mohd Ahmed, H., Abdel Aziz, K., Al Ammari, A., Galadari, M., Alsaadi, A., Alhassani, A., … Aly El-Gabry, D. (2024). International Journal of Psychiatry in Clinical Practice, 28(1), 35–44. https://doi.org/10.1080/13651501.2024.2310847Medical Arab Board